end of compounded semaglutide Novo Nordisk's shortage officially concludes in the US, spelling major threat for weight loss drug compounders Fridays | GLP-1 Telehealth |

DISMUTASE THO

Psoriasis patients with nail disease have a greater magnitude of underlying systemic subclinical enthesopathy than those with normal nails

The leading hypothesis to reconcile these findings is the early worsening phenomenon, where rapid and substantial glycemic improvement temporarily exacerbates pre-existing DR

The results showed that all three doses of tirzepatide led to more significant weight loss than 1mg of semaglutide

Alcohol can increase side effects and may reduce the overall effectiveness of GLP-1 medications

Enter Retatrutide Retatrutide is the first triple agonist targeting 3 metabolic receptors at once: GLP-1: Enhances insulin, reduces appetite, slows digestion GIP: Boosts insulin, improves lipid metabolism GCGR: Increases energy expenditure, burns fat GLP-1 activation stimulates insulin secretion from pancreatic -cells, reduces appetite through central pathways, and slows gastric emptying to reduce glucose spikes